Cannabinoid Ligands Targeting TRP Channels - PubMed
- ️Tue Jan 01 2019
Review
Cannabinoid Ligands Targeting TRP Channels
Chanté Muller et al. Front Mol Neurosci. 2019.
Abstract
Transient receptor potential (TRP) channels are a group of membrane proteins involved in the transduction of a plethora of chemical and physical stimuli. These channels modulate ion entry, mediating a variety of neural signaling processes implicated in the sensation of temperature, pressure, and pH, as well as smell, taste, vision, and pain perception. Many diseases involve TRP channel dysfunction, including neuropathic pain, inflammation, and respiratory disorders. In the pursuit of new treatments for these disorders, it was discovered that cannabinoids can modulate a certain subset of TRP channels. The TRP vanilloid (TRPV), TRP ankyrin (TRPA), and TRP melastatin (TRPM) subfamilies were all found to contain channels that can be modulated by several endogenous, phytogenic, and synthetic cannabinoids. To date, six TRP channels from the three subfamilies mentioned above have been reported to mediate cannabinoid activity: TRPV1, TRPV2, TRPV3, TRPV4, TRPA1, and TRPM8. The increasing data regarding cannabinoid interactions with these receptors has prompted some researchers to consider these TRP channels to be "ionotropic cannabinoid receptors." Although CB1 and CB2 are considered to be the canonical cannabinoid receptors, there is significant overlap between cannabinoids and ligands of TRP receptors. The first endogenous agonist of TRPV1 to be discovered was the endocannabinoid, anandamide (AEA). Similarly, N-arachidonyl dopamine (NADA) and AEA were the first endogenous TRPM8 antagonists discovered. Additionally, Δ9-tetrahydrocannabinol (Δ9-THC), the most abundant psychotropic compound in cannabis, acts most potently at TRPV2, moderately modulates TRPV3, TRPV4, TRPA1, and TRPM8, though Δ9-THC is not reported to modulate TRPV1. Moreover, TRP receptors may modulate effects of synthetic cannabinoids used in research. One common research tool is WIN55,212-2, a CB1 agonist that also exerts analgesic effects by desensitizing TRPA1 and TRPV1. In this review article, we aim to provide an overview and classification of the cannabinoid ligands that have been reported to modulate TRP channels and their therapeutic potential.
Keywords: TRP channels; TRPA1; TRPM8; TRPV1; cannabidiol; cannabinoids.
Figures

General topology of the transient receptor potential (TRP) channels discussed in this review: TRPV1–4, TRPA1 and TRPM8.

The lipid view of TRPV1 adapted from PDB: 3J5P. Ankyrin repeat domain (ARD) shown in red, transmembrane helices shown in yellow, TRP domain shown in purple, and intracellular regions (ICRs) and extracellular regions (ECRs) shown in green. Sections have been omitted for clarity.

(A) The lipid view of TRPA1 adapted from PDB: 3J9P. ARD shown in red, transmembrane region (TMR) shown in yellow, TRP-like domain shown in purple, ICRs- and ECRs shown in green and coiled-coil shown in pink. Sections have been omitted for clarity. (B) The intracellular view of TRPA1 adapted from PDB: 3J9P. Coiled-coil shown in pink. Sections have been omitted for clarity.

Structure of selected endocannabinoids that target TRP channels.

Structure of selected plant cannabinoid ligands that target TRP channels.

Structure of selected synthetic cannabinoid ligands that target TRP channels: (A) aminoalkyindole derivatives; (B) arylpyrazole derivatives; (C) synthetic phytocannabinoids analogs.
Similar articles
-
Oakes M, Law WJ, Komuniecki R. Oakes M, et al. J Neurosci. 2019 May 22;39(21):4142-4152. doi: 10.1523/JNEUROSCI.2371-18.2019. Epub 2019 Mar 18. J Neurosci. 2019. PMID: 30886012 Free PMC article.
-
De Petrocellis L, Orlando P, Moriello AS, Aviello G, Stott C, Izzo AA, Di Marzo V. De Petrocellis L, et al. Acta Physiol (Oxf). 2012 Feb;204(2):255-66. doi: 10.1111/j.1748-1716.2011.02338.x. Epub 2011 Aug 12. Acta Physiol (Oxf). 2012. PMID: 21726418
-
An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors.
Muller C, Reggio PH. Muller C, et al. Front Cell Neurosci. 2020 Dec 9;14:615811. doi: 10.3389/fncel.2020.615811. eCollection 2020. Front Cell Neurosci. 2020. PMID: 33362478 Free PMC article.
-
Pharmacological actions of cannabinoids.
Pertwee RG. Pertwee RG. Handb Exp Pharmacol. 2005;(168):1-51. doi: 10.1007/3-540-26573-2_1. Handb Exp Pharmacol. 2005. PMID: 16596770 Review.
-
Premkumar LS, Abooj M. Premkumar LS, et al. Life Sci. 2013 Mar 19;92(8-9):415-24. doi: 10.1016/j.lfs.2012.08.010. Epub 2012 Aug 14. Life Sci. 2013. PMID: 22910182 Free PMC article. Review.
Cited by
-
Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection.
de Brito Siqueira ALG, Cremasco PVV, Bahú JO, Pioli da Silva A, Melo de Andrade LR, González PGA, Crivellin S, Cárdenas Concha VO, Krambeck K, Lodi L, Severino P, Souto EB. de Brito Siqueira ALG, et al. J Tradit Complement Med. 2023 Aug 26;13(6):575-587. doi: 10.1016/j.jtcme.2023.08.006. eCollection 2023 Nov. J Tradit Complement Med. 2023. PMID: 38020546 Free PMC article. Review.
-
Cannabinoids activate the insulin pathway to modulate mobilization of cholesterol in C. elegans.
Hernandez-Cravero B, Gallino S, Florman J, Vranych C, Diaz P, Elgoyhen AB, Alkema MJ, de Mendoza D. Hernandez-Cravero B, et al. PLoS Genet. 2022 Nov 8;18(11):e1010346. doi: 10.1371/journal.pgen.1010346. eCollection 2022 Nov. PLoS Genet. 2022. PMID: 36346800 Free PMC article.
-
Modulation of Recombinant Human T-Type Calcium Channels by Δ9-Tetrahydrocannabinolic Acid In Vitro.
Mirlohi S, Bladen C, Santiago M, Connor M. Mirlohi S, et al. Cannabis Cannabinoid Res. 2022 Feb;7(1):34-45. doi: 10.1089/can.2020.0134. Epub 2021 Jan 21. Cannabis Cannabinoid Res. 2022. PMID: 33998881 Free PMC article.
-
Tyrakis P, Agridi C, Kourti M. Tyrakis P, et al. Int J Mol Sci. 2024 Aug 7;25(16):8630. doi: 10.3390/ijms25168630. Int J Mol Sci. 2024. PMID: 39201317 Free PMC article. Review.
-
Antiallodynic effect of PhAR-DBH-Me involves cannabinoid and TRPV1 receptors.
Quiñonez-Bastidas GN, Palomino-Hernández O, López-Ortíz M, Rocha-González HI, González-Anduaga GM, Regla I, Navarrete A. Quiñonez-Bastidas GN, et al. Pharmacol Res Perspect. 2020 Oct;8(5):e00663. doi: 10.1002/prp2.663. Pharmacol Res Perspect. 2020. PMID: 32965798 Free PMC article.
References
-
- Ahluwalia J., Urban L., Bevan S., Nagy I. (2003). Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci. 17, 2611–2618. 10.1046/j.1460-9568.2003.02703.x - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources